A Study to Evaluate Multiple Doses of GLPG2222 in Adult Subjects With Cystic Fibrosis
Clinical trial NCT03119649 · COMPLETED
Trial details
- NCT number
- NCT03119649
- Sponsor
- Lakefront Biotherapeutics NV
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-18
- Primary completion
- 2017-10-19
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.